424 related articles for article (PubMed ID: 25232261)
1. Smoking increases the risk of extraintestinal manifestations in Crohn's disease.
Ott C; Takses A; Obermeier F; Schnoy E; Müller M
World J Gastroenterol; 2014 Sep; 20(34):12269-76. PubMed ID: 25232261
[TBL] [Abstract][Full Text] [Related]
2. Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort.
Isene R; Bernklev T; Høie O; Munkholm P; Tsianos E; Stockbrügger R; Odes S; Palm Ø; Småstuen M; Moum B;
Scand J Gastroenterol; 2015 Mar; 50(3):300-5. PubMed ID: 25535653
[TBL] [Abstract][Full Text] [Related]
3. [Incidence and risk factors of extraintestinal manifestations in children with inflammatory bowel disease].
Shan CY; Zhang QQ; Xiao Y; Wang XQ; Yu Y; Xu X; Xu CD
Zhonghua Er Ke Za Zhi; 2019 Sep; 57(9):694-699. PubMed ID: 31530355
[No Abstract] [Full Text] [Related]
4. The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients.
Roth R; Vavricka S; Scharl M; Schreiner P; Safroneeva E; Greuter T; Zeitz J; Misselwitz B; Schoepfer A; Barry MP; Rogler G; Biedermann L;
United European Gastroenterol J; 2021 Sep; 9(7):773-780. PubMed ID: 34431613
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease.
Karmiris K; Avgerinos A; Tavernaraki A; Zeglinas C; Karatzas P; Koukouratos T; Oikonomou KA; Kostas A; Zampeli E; Papadopoulos V; Theodoropoulou A; Viazis N; Polymeros D; Michopoulos S; Bamias G; Kapsoritakis A; Karamanolis DG; Mantzaris GJ; Tzathas C; Koutroubakis IE
J Crohns Colitis; 2016 Apr; 10(4):429-36. PubMed ID: 26721936
[TBL] [Abstract][Full Text] [Related]
6. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study.
Lakatos L; Pandur T; David G; Balogh Z; Kuronya P; Tollas A; Lakatos PL
World J Gastroenterol; 2003 Oct; 9(10):2300-7. PubMed ID: 14562397
[TBL] [Abstract][Full Text] [Related]
7. Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotype.
Singh B; Kedia S; Konijeti G; Mouli VP; Dhingra R; Kurrey L; Srivastava S; Pradhan R; Makharia G; Ahuja V
Indian J Gastroenterol; 2015 Jan; 34(1):43-50. PubMed ID: 25663290
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Extraintestinal Manifestations in Inflammatory Bowel Diseases - Data from the Romanian National Registry.
Singeap AM; Girleanu I; Diculescu M; Gheorghe L; Ciocîrlan M; Gheorghe C; Costache A; Tanțău A; Zaharie R; Goldis A; Gheonea D; Dobru D; Dumitru E; Prelipcean CC; Gîlcă-Blanariu GE; Moscalu M; Stanciu C; Trifan A
J Gastrointestin Liver Dis; 2021 Sep; 30(3):346-357. PubMed ID: 34375380
[TBL] [Abstract][Full Text] [Related]
9. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients.
Zippi M; Corrado C; Pica R; Avallone EV; Cassieri C; De Nitto D; Paoluzi P; Vernia P
World J Gastroenterol; 2014 Dec; 20(46):17463-7. PubMed ID: 25516659
[TBL] [Abstract][Full Text] [Related]
10. Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking.
Roberts H; Rai SN; Pan J; Rao JM; Keskey RC; Kanaan Z; Short EP; Mottern E; Galandiuk S
Digestion; 2014; 90(2):122-9. PubMed ID: 25277851
[TBL] [Abstract][Full Text] [Related]
11. Severe Disease Activity Based on the Paris Classification Is Associated with the Development of Extraintestinal Manifestations in Korean Children and Adolescents with Ulcerative Colitis.
Jang HJ; Suh HR; Choi S; Hong SJ; Cho SM; Choi KH; Choe BH; Kang B;
J Korean Med Sci; 2021 Nov; 36(44):e278. PubMed ID: 34783212
[TBL] [Abstract][Full Text] [Related]
12. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease.
Jose FA; Garnett EA; Vittinghoff E; Ferry GD; Winter HS; Baldassano RN; Kirschner BS; Cohen SA; Gold BD; Abramson O; Heyman MB
Inflamm Bowel Dis; 2009 Jan; 15(1):63-8. PubMed ID: 18626963
[TBL] [Abstract][Full Text] [Related]
13. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
14. Temporal Relationship of Extraintestinal Manifestations in Inflammatory Bowel Disease.
Fedor I; Zold E; Barta Z
J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945280
[TBL] [Abstract][Full Text] [Related]
15. The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
King D; Chandan JS; Thomas T; Nirantharakumar K; Reulen RC; Adderley NJ; Trudgill N
Inflamm Bowel Dis; 2021 Oct; 27(11):1731-1739. PubMed ID: 34669933
[TBL] [Abstract][Full Text] [Related]
16. Extraintestinal manifestation of inflammatory bowel disease in Asian patients: A multinational study.
Park SK; Wong Z; Park SH; Vu KV; Bang KB; Piyachaturawat P; Myint T; Hilmi I; Park DI
Dig Liver Dis; 2021 Feb; 53(2):196-201. PubMed ID: 32736897
[TBL] [Abstract][Full Text] [Related]
17. Clinical Features Focusing on Extraintestinal Manifestations in Japanese Patients with Inflammatory Bowel Diseases: Far East 1000.
Ohta Y; Taida T; Kato J; Ogasawara S; Oyama Y; Mamiya Y; Nakazawa H; Horio R; Goto C; Takahashi S; Kurosugi A; Sonoda M; Shiratori W; Kaneko T; Yokoyama Y; Akizue N; Ishigami H; Koseki H; Okimoto K; Saito K; Saito M; Matsumura T; Nakagawa T; Masuya Y; Fukuda Y; Kitsukawa Y; Shimura H; Tsuyuguchi T; Kato N
Digestion; 2023; 104(4):328-334. PubMed ID: 36893744
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
[TBL] [Abstract][Full Text] [Related]
19. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.
Vavricka SR; Brun L; Ballabeni P; Pittet V; Prinz Vavricka BM; Zeitz J; Rogler G; Schoepfer AM
Am J Gastroenterol; 2011 Jan; 106(1):110-9. PubMed ID: 20808297
[TBL] [Abstract][Full Text] [Related]
20. Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: a cross-sectional study.
Carpio D; Barreiro-de Acosta M; Echarri A; Pereira S; Castro J; Ferreiro R; Lorenzo A;
Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1030-7. PubMed ID: 26049704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
